Cabazitaxel in patients with refractory recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Final results of phase I...
| Date | 26 September 2015 |
| Event | European Cancer Congress 2015 |
| Session | Head and Neck Cancer |
| Topics | Head and Neck Cancers |
| Presenter | Fayette, J. |